WuXi Clinical, a wholly owned subsidiary of WuXi AppTec, is a global Contract Research Organization (CRO) providing a comprehensive range of services in clinical development. We provide Phase I to Phase IV research & Bioequivalence (BE) studies for pharmaceuticals, biologics, and medical devices. With expertise spanning across all major therapeutic areas, we deliver the unique blend of an experienced team combined with data-driven insights and responsiveness for better outcomes. Our forward-thinking approach has allowed us to accelerate a variety of clinical projects ranging from first-in-human products to marketed drugs and devices.